Skip to main content

Table 1 Clinical characteristics of a cohort of 33 brain specimens from people with HIV

From: Transcriptomic analysis of brain tissues identifies a role for CCAAT enhancer binding protein β in HIV-associated neurocognitive disorder

 

Cognitive normal (n = 10)

Asymptomatic neurocognitive impairment (n = 10)

Minor neurocognitive dysfunction (n = 10)

HIV-associated dementia (n = 3)

Age

41.7 ± 8.1

41.7 ± 10.8

43.1 ± 6.7

40.7 ± 2.1

Sex (fm:m)

0:10

1:09

1:09

1:02

Postmortem interval

33.3 ± 67.5

21.4 ± 28.4

15.5 ± 14.4

9.3 ± 3.01

Education

13.0 ± 2.3

12.22 ± 3.4

12.0 ± 3.46

16.0 ± 3.5

CD4

151.6 ± 151.2

68.7 ± 73.9

35.3 ± 55.4

98.0 ± 155.1

VL (log)

3.3 ± 1.6

3.9 ± 1.3

5.0 ± 0.8

4.4 ± 2.4

Duration on ART (months)

53.3 ± 28.2

56.3 ± 86.5

35.7 ± 19.6

16.0 ± 0.0